


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.19%
-0.31%
+0.63%
-17.70%
CRVS
Corvus Pharmaceutica
$22.15
CRVS Price Performance
$7.37 (+200.54%)
$7.86 (+181.81%)
$5.41 (+309.43%)
$5.39 (+310.95%)
CRVS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
CRVS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CRVS Street Sentiment is bullish and have negative views on the near-term outlook
CRVS has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
What is CRVS current stock price?
What are CRVS stock strengths?
What is CRVS Risk Level?
What is CRVS market cap and volume?
What is CRVS current Stock IQ?
Should I buy CRVS stock right now?
Is CRVS a Strong Buy right now?
What does a 'Strong Buy' rating mean for CRVS?
What does a 'Strong Sell' rating mean for CRVS?
What factors influence CRVS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.19%
-0.31%
+0.63%
-17.70%
CRVS
Corvus Pharmaceutica
Current Price
$22.15
Stock Insights
Not Enough Information

CRVS Price Performance
$7.37 (+200.54%)
$7.86 (+181.81%)
$5.41 (+309.43%)
$5.39 (+310.95%)
CRVS Analysts Opinion
CRVS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
CRVS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CRVS Street Sentiment is bullish and have negative views on the near-term outlook
CRVS has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
CRVS Stock IQ
CRVS Latest Analysis
Smart Money Is Betting Big In CRVS Options. Investors with a lot of money to spend have taken a bearish stance on CRVS).And retail traders should know.We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals we don'.t know. But when something this big happens with CRVS it often means somebody knows something is about to happen.Today Benzinga'.s options scanner spotted
Wed Jan 21, 2026
Corvus Pharma Commences Public Offering Of $150 Mln Of Shares. Stock Down . (RTTNews) - Corvus Pharmaceuticals Inc. (CRVS) a clinical-stage biopharmaceutical company announced that it has initiated a public offering of $150 million of shares of its common stock including pre-funded warrants of its common stock for certain investors.
Wed Jan 21, 2026
Corvus Pharma stock falls after announcing $150 million offering.
Tue Jan 20, 2026
Why Small Biotech Stock Corvus Pharma Just Launched To An Eight-Year High. Biotech stock Corvus Pharmaceuticals catapulted to an eight-year high Tuesday on promising results in eczema treatment.The post Why Small Biotech Stock Corvus Pharma Just Launched To An Eight-Year High appeared first on Investor'.s Business Daily.
Tue Jan 20, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CRVS Stock trends
CRVS Stock performance
CRVS Stock analysis
CRVS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.